| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Revenue | $555.7M (+3% seq, -10% YoY) | $424.5M (-24% seq, +14% YoY) | Beat guide by $14.5M on sustained demand |
| Full Year Revenue | $1.79B (+3% YoY) | $1.9B (+6% YoY) | Accelerated growth from new products |
| Non-GAAP Gross Margin | 53.6% (+140bps seq) | 53.5% (+380bps YoY) | Stable at elevated levels from mix |
| Non-GAAP Operating Margin | 30.4% of revenue | 25.2% of revenue | 500bps compression on lower revenue base |
| Non-GAAP EPS | $2.51 | $1.67 (-33% seq) | Full year record $7.54 vs $6.59 prior |
| Cash and Investments | $816.6M | $835M (+$134.9M YoY) | Strong cash generation despite buybacks |
| Days of Inventory | 98 days | 138 days (+40 days seq) | Major inventory build for capacity agreement |
| Free Cash Flow Margin | 38% in Q3 | 29% in Q4 | Full year 22% vs 25% trailing twelve |
| Share Repurchases | $70M in Q3 | $100M in Q4 | Record $261M full year vs prior |
| Operating Expenses | $129.2M | $120M (-$9.2M seq) | Lower employee expenses and tape-out timing |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.